GUARDANT HEALTH CL. A revenue for the last year amounted to 510.94 M EUR, the most of which — 465.91 M EUR — came from its highest performing source at the moment, Precision Oncology Testing, the year earlier bringing 366.32 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought GUARDANT HEALTH CL. A 477.04 M EUR, and the year before that — 393.01 M EUR.